ATP-sensitive K+ channel effects on nerve function, Na+, K+ ATPase, and glutathione in diabetic rats

European Journal of Pharmacology

Volumn 397, Issue 2-3, 2000, Pages 335-341

  Hohman, Thomas C ^a   Cotter, Mary A ^b   Cameron, Norman E ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Blood flow; Diabetic rat; Glutathione; K+ channel opener; Na+, K+ ATPase; Nerve conduction; Neuropathy; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CELIKALIM; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; UNCLASSIFIED DRUG; WAY 135201;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; MALE; NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANISOLES; BENZOPYRANS; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GLUTATHIONE; INDOLES; MALE; NA(+)-K(+)-EXCHANGING ATPASE; POTASSIUM CHANNELS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE;

EID: 0034595563     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00227-2     Document Type: Article

References (38)

1. Brismar T. Potential clamp analysis of the effect of anoxia on the nodal function of rat peripheral nerve fibres. Acta Physiol. Scand. 112:1981;495-496.
2. Brismar T., Sima A.A.F. Changes in nodal function in nerve fibres of the spontaneously diabetic BB-Wistar rat: potential clamp analysis. Acta Physiol. Scand. 113:1981;499-506.
3. Cameron N.E., Cotter M.A. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: role of the polyol pathway. Diabetologia. 35:1992;1011-1019.
4. Cameron N.E., Cotter M.A. Contraction and relaxation of aortas from galactosaemic rats and the effects of polyol pathway inhibition. Eur. J. Pharmacol. 243:1993;47-53.
5. Cameron N.E., Cotter M.A. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab. Rev. 10:1994;189-224.
6. Cameron N.E., Cotter M.A. Effects of a non-peptide endothelin-1 ETA antagonist on neurovascular function in diabetic rats: interaction with the renin-angiotensin system. J. Pharmacol. Exp. Ther. 278:1996;1262-1268.
7. Cameron N.E., Cotter M.A., Ferguson K., Robertson S., Radcliffe M.A. Effects of chronic α-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na-K ATPase activity and vascular supply in STZ-diabetic rats. Diabetes. 40:1991;1652-1658.
8. Cameron N.E., Cotter M.A., Dines K.C., Maxfield E.K., Carey F., Mirrlees D.J. Aldose reductase inhibition, nerve perfusion, oxygenation and function in streptozotocin-diabetic rats: dose-response considerations and independence from a myo-inositol mechanism. Diabetologia. 37:1994;651-663.
9. Cameron N.E., Cotter M.A., Archibald V., Dines K.C., Maxfield E.K. Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia. 37:1994;449-459.
10. Cameron N.E., Cotter M.A., Hohman T.C. Interactions between essential fatty acid, prostanoid, polyol pathway and nitric oxide mechanisms in the neurovascular deficit of diabetic rats. Diabetologia. 39:1996;172-182.
11. Cameron N.E., Cotter M.A., Horrobin D.H., Tritschler H.J. Effects of α-lipoic acid on neurovascular function in diabetic rats: interaction with essential fatty acids. Diabetologia. 41:1998;390-399.
12. +-ATPase activity and glutathione content in diabetic rats. Diabetologia. 42:1999;1120-1130.
13. + ATP channels mediate vasodilator responses to histamine in the cat. Am. J. Physiol. 273:1997;H928-H937.
14. 1 adrenoceptor antagonist treatment: interactions with the nitric oxide system. Eur. J. Pharmacol. 343:1998;217-223.
15. 2 clearance curves used to measure blood flow in rat sciatic nerve. J. Physiol. 414:1989;35-54.
16. Fox J.S., Whitehead E.M., Shanks R.G. Cardiovascular effects of cromakalim (BRL 34915) in healthy volunteers. Br. J. Clin. Pharmacol. 32:1991;45-49.
17. + channels, in the aorta from streptozotocin-treated diabetic rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;210-215.
18. Greene D.A., Sima A.A.F., Stevens M.J., Feldman E.L., Lattimer S.A. Complications: neuropathy, pathogenetic considerations. Diabetes Care. 15:1992;1902-1925.
19. Hohman T.C., Banas D., Basso M., Cotter M.A., Cameron N.E. Increased oxidative stress in experimental diabetic neuropathy. Diabetologia. 40(Suppl. 1):1997;A549. (Abstract).
20. Jack A., Cameron N.E., Cotter M.A. Effects of the diacylglycerol complexing agent, cremophor, on nerve conduction velocity and perfusion in diabetic rats. J. Diabetes Complications. 13:1999;2-9.
21. Kamata K., Miyata N., Kasuya Y. Functional changes in potassium channels in aortas from rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 166:1989;319-323.
22. 2+ antagonist, nimodipine, on existing diabetic neuropathy in the BB/Wor rat. Br. J. Pharmacol. 111:1994;887-893.
23. Kihara M., Low P.A. Impaired vasoreactivity to nitric oxide in experimental diabetic neuropathy. Exp. Neurol. 132:1995;180-185.
24. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes. 47:1998;859-866.
25. + currents in rat arterial smooth muscle through protein kinase C. J. Physiol. 503:1997;489-496.
26. Love A., Cotter M.A., Cameron N.E. Nerve function and regeneration in diabetic and galactosaemic rats: antioxidant and metal chelator effects. Eur. J. Pharmacol. 314:1996;33-39.
27. + channels, potassium and muscle vasodilatation in the rat in systemic hypoxia. J. Physiol. 472:1993;1-9.
28. Maxfield E.K., Cameron N.E., Cotter M.A. Effect of diabetes on reactivity of sciatic vasa nervorum in rats. J. Diabetes Complications. 11:1997;47-55.
29. McManis P.G., Low P.A., Yao J.K. The relationship between nerve blood flow and intercapillary distance in peripheral nerve edema. Am. J. Physiol. 251:1986;E92-E97.
30. +)-ATPase activity in galactose intoxication. Metabolism. 40:1991;1207-1212.
31. Mizisin A.P., Powell H.C., Myers R.R. Edema and increased endoneurial sodium in galactose neuropathy. Reversal with an aldose reductase inhibitor. J. Neurol. Sci. 74:1986;35-43.
32. Nagamatsu M., Nickander K.K., Schmelzer J.D., Raya A., Wittrock A., Tritschler H., Low P.A. Lipoic acid improves nerve blood flow, reduces oxidative stress and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 18:1995;1160-1167.
33. Tesfaye S., Malik R., Ward J.D. Vascular factors in diabetic neuropathy. Diabetologia. 37:1994;847-854.
34. Tosaki A., Engelman D.T., Engelman R.M., Das D.K. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts. J. Pharmacol. Exp. Ther. 275:1995;1115-1123.
35. Tuck R.R., Schmelzer J.D., Low P.A. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 107:1984;935-950.
36. Ward K.K., Low P.A., Schmelzer J.D., Zochodne D.W. Prostacyclin and noradrenaline in peripheral nerve of chronic experimental diabetes in rats. Brain. 112:1989;197-208.
37. + channels in pancreatic, cardiac, and vascular smooth muscle cells. Am. J. Physiol. 274:1998;C25-C37.
38. + channel openers in cerebral arteries from diabetic rats. Circ. Res. 81:1997;996-1004.